Page 3 - நேரம் ரீகந் ஸ்காட் எக்‌ஸ்டீந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நேரம் ரீகந் ஸ்காட் எக்‌ஸ்டீந். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நேரம் ரீகந் ஸ்காட் எக்‌ஸ்டீந் Today - Breaking & Trending Today

Cybin Inc. Releases Financial Highlights and Provides Business Update


 Cybin Inc. Releases Financial Highlights and Provides Business Update
Successful bought deal offering brings total capital raised to-date to approximately $90 million Increased patent applications filed to 10, covering novel molecules, delivery systems, deuterated tryptamines and phenethylamines – Adelia Therapeutics acquisition expands scientific team, IP portfolio and diversifies development pipeline Partnership with Kernel provides access to neuroimaging …
Successful bought deal offering brings total capital raised to-date to approximately $90 million
Increased patent applications filed to 10, covering novel molecules, delivery systems, deuterated tryptamines and phenethylamines –
Adelia Therapeutics acquisition expands scientific team, IP portfolio and diversifies development pipeline
Partnership with Kernel provides access to neuroimaging technology, enabling the potential quantification of psychedelic therapeutics – ....

United States , Lisam Wilson , Doug Drysdale , Alex Nivorozhkin , Tim Regan Scott Eckstein , Jukka Karjalainen , Jacqueline Poriadjian , Annie Graf , Brett Greene , Michael Palfreyman , Gabriel Fahel , Cybin Inc , Regulatory Affairs , Drug Administration , Site Communications Inc , Strategic Communications , Adelia Therapeutics Inc , Health Canada , Adelia Therapeutics , Kernel Flow , Chief Executive , Lori Challenger , Chief Research Officer , Chief Science Officer , Chief Innovation Officer , Aaron Bartlone ,

Cybin to Provide Business Update on February 17, 2021 Conference Call


Cybin to Provide Business Update on February 17, 2021 Conference Call
Cybin Inc. a biotechnology company focused on progressing psychedelic therapeutics, today announced that Doug Drysdale, Chief Executive Officer, will conduct a conference call and webcast to review its financial results and provide a business update as follows: A replay of the conference call will be available for two weeks after the call’s completion by dialing 512-2921 or 317-6671 . The conference ID for the …
Date
A replay of the conference call will be available for two weeks after the call’s completion by dialing (844) 512-2921 (U.S.) or (412) 317-6671 (International). The conference ID for the replay is 13716476. The archived webcast will be available for 30 days on: www.cybin.com/investor-relations . ....

Lisam Wilson , Annie Graf , Doug Drysdale , Tim Regan Scott Eckstein , Jackie Poriadjian , Strategic Communications , Cybin Inc , Drug Administration , Health Canada , Site Communications Inc , Chief Executive Officer , Site Communications , Marketing Officer , அன்னயே கிராப் , டக் ட்ரைஸ்டேல் , நேரம் ரீகந் ஸ்காட் எக்‌ஸ்டீந் , மூலோபாய தகவல்தொடர்புகள் , ஆரோக்கியம் கனடா , தளம் தகவல்தொடர்புகள் இன்க் , தலைமை நிர்வாகி அதிகாரி , தளம் தகவல்தொடர்புகள் , சந்தைப்படுத்தல் அதிகாரி ,